• 1. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Aromatic monoterpenoids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Monoterpenoids Aromatic monoterpenoids

Recent Advances in the Study of 2-Thymyloxyethanol (CAS: 55129-21-0): A Comprehensive Research Brief

2-Thymyloxyethanol (CAS: 55129-21-0) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This compound, derived from thymol, has shown promising potential in various applications, including antimicrobial, anti-inflammatory, and therapeutic uses. Recent studies have focused on elucidating its mechanism of action, optimizing its synthesis, and exploring its biomedical applications. This research brief aims to provide an up-to-date overview of the latest findings related to 2-Thymyloxyethanol, highlighting its potential in drug development and other medical applications.

One of the key areas of research has been the antimicrobial properties of 2-Thymyloxyethanol. A study published in the Journal of Medicinal Chemistry (2023) demonstrated its efficacy against a broad spectrum of Gram-positive and Gram-negative bacteria, including antibiotic-resistant strains. The compound's ability to disrupt bacterial cell membranes and inhibit biofilm formation makes it a promising candidate for developing new antimicrobial agents. Furthermore, its low cytotoxicity to mammalian cells enhances its potential for therapeutic use.

In addition to its antimicrobial activity, 2-Thymyloxyethanol has been investigated for its anti-inflammatory effects. Research conducted at the University of Cambridge (2024) revealed that the compound can modulate the NF-κB signaling pathway, thereby reducing the production of pro-inflammatory cytokines. This finding suggests its potential application in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease. The study also highlighted the compound's ability to synergize with existing anti-inflammatory drugs, potentially reducing the required dosage and minimizing side effects.

The synthesis and optimization of 2-Thymyloxyethanol have also been a focus of recent research. A team at MIT (2024) developed a novel, cost-effective method for synthesizing the compound with high purity and yield. This advancement addresses previous challenges related to scalability and production costs, paving the way for its broader application in pharmaceutical formulations. The study also explored the structure-activity relationship (SAR) of 2-Thymyloxyethanol, identifying key functional groups that contribute to its biological activity.

Another promising area of research involves the use of 2-Thymyloxyethanol in drug delivery systems. A recent study published in Advanced Drug Delivery Reviews (2024) demonstrated its potential as a solubilizing agent for poorly water-soluble drugs. The compound's amphiphilic nature allows it to enhance the bioavailability of hydrophobic drugs, making it a valuable component in nanocarrier systems. This application could significantly improve the efficacy of various therapeutic agents, particularly in oncology and infectious disease treatments.

Despite these advancements, challenges remain in the clinical translation of 2-Thymyloxyethanol. Issues such as pharmacokinetics, long-term toxicity, and regulatory approval need to be addressed. Ongoing research is focused on conducting preclinical and clinical trials to evaluate the safety and efficacy of the compound in humans. Collaborative efforts between academia and industry are essential to accelerate the development of 2-Thymyloxyethanol-based therapies.

In conclusion, 2-Thymyloxyethanol (CAS: 55129-21-0) represents a versatile and promising compound in the field of chemical biology and pharmaceutical research. Its antimicrobial, anti-inflammatory, and drug delivery applications highlight its potential to address unmet medical needs. Continued research and development efforts are crucial to fully realize its therapeutic potential and bring it to the market. This research brief underscores the importance of interdisciplinary collaboration and innovation in advancing the field of chemical biology and medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)